SCHEMBL27237391

SCHEMBL27237391

COc1cc(C=NNC(=O)c2cc(-c3ccc(OC4CCCC4)cc3)ccn2)cc(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 3/20 0.47
▸ MAPT P10636 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MGAM O43451 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ AMY1A P0DUB6 1/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003166 1.00 FDPS (0.47) FDPSMAPTSMN1; SMN2KMT2AMEN1
SCHEMBL30951018 1.00 FDPS (0.47) FDPSMAPTSMN1; SMN2KMT2AMEN1
SCHEMBL27237488 0.88 HDAC6 (0.47) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL25002987 0.88 HDAC6 (0.47) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL30171377 0.85 MAPT (0.52) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL25002958 0.85 MAPT (0.52) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL27237434 0.85 MAPT (0.52) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL25002954 0.84 ALDH1A1 (0.50) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL30862201 0.84 ALDH1A1 (0.50) MAPTSMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL27237475 0.84 ALDH1A1 (0.50) MAPTSMN1; SMN2KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
Send feedback